Literature DB >> 17875605

Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer.

Wolfgang Kemmner1, Kayiu Wan, Steffen Rüttinger, Bernd Ebert, Rainer Macdonald, Ursula Klamm, K Thomas Moesta.   

Abstract

Hemes and heme proteins are vital components of essentially every cell of virtually every eukaryote organism. Previously, we demonstrated accumulation of the heme precursor protoporphyrin-IX (PpIX) in gastrointestinal tumor tissues. To elucidate the mechanisms of PpIX accumulation by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR), we studied expression of the relevant enzymes of the heme synthetic pathway. Here, we describe a significant down-regulation of ferrochelatase (FECH) mRNA expression in gastric, colonic, and rectal carcinomas. Accordingly, in an in vitro model of several carcinoma cell lines, ferrochelatase down-regulation and loss of enzymatic activity corresponded with an enhanced PpIX-dependent fluorescence. Direct detection of PpIX in minute amounts was achieved by a specifically developed pulsed solid-state laser dual delay fluorimetry setup. Silencing of FECH using small interfering RNA (siRNA) technology led to a maximum 50-fold increased PpIX accumulation, imageable by a specifically adapted two-photon microscopy unit. Our results show that in malignant tissue a transcriptional down-regulation of FECH occurs, which causes endogenous PpIX accumulation. Furthermore, accumulation of intracellular PpIX because of FECH siRNA silencing provides a small-molecule-based approach to molecular imaging and molecular therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875605     DOI: 10.1096/fj.07-8888com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  32 in total

1.  [Advances in endoscopic diagnosis of dysplasia and carcinoma of the larynx].

Authors:  C Arens; U Vorwerk; T Just; C S Betz; M Kraft
Journal:  HNO       Date:  2012-01       Impact factor: 1.284

2.  Chronic Treatment with Isoniazid Causes Protoporphyrin IX Accumulation in Mouse Liver.

Authors:  Madhav Sachar; Feng Li; Ke Liu; Pengcheng Wang; Jie Lu; Xiaochao Ma
Journal:  Chem Res Toxicol       Date:  2016-08-02       Impact factor: 3.739

3.  Ferrochelatase Deficiency Abrogated the Enhancement of Aminolevulinic Acid-mediated Protoporphyrin IX by Iron Chelator Deferoxamine.

Authors:  Pratheeba Palasuberniam; Daniel Kraus; Matthew Mansi; Alexander Braun; Richard Howley; Kenneth A Myers; Bin Chen
Journal:  Photochem Photobiol       Date:  2019-03-15       Impact factor: 3.421

4.  Iron chelators in photodynamic therapy revisited: synergistic effect by novel highly active thiosemicarbazones.

Authors:  Anna Mrozek-Wilczkiewicz; Maciej Serda; Robert Musiol; Grzegorz Malecki; Agnieszka Szurko; Angelika Muchowicz; Jakub Golab; Alicja Ratuszna; Jaroslaw Polanski
Journal:  ACS Med Chem Lett       Date:  2014-01-23       Impact factor: 4.345

5.  Nickel(II) chelatase variants directly evolved from murine ferrochelatase: porphyrin distortion and kinetic mechanism.

Authors:  Neil R McIntyre; Ricardo Franco; John A Shelnutt; Gloria C Ferreira
Journal:  Biochemistry       Date:  2011-02-10       Impact factor: 3.162

6.  Sodium butyrate increases the effect of the photodynamic therapy: a mechanism that involves modulation of gene expression and differentiation in astrocytoma cells.

Authors:  José Bueno-Carrazco; Violeta Castro-Leyva; Fanny García-Gomez; Mario Solís-Paredes; Eva Ramon-Gallegos; Alfredo Cruz-Orea; Pilar Eguía-Aguilar; Francisco Arenas-Huertero
Journal:  Childs Nerv Syst       Date:  2012-06-19       Impact factor: 1.475

Review 7.  Nanomedicines for Endometriosis: Lessons Learned from Cancer Research.

Authors:  Abraham S Moses; Ananiya A Demessie; Olena Taratula; Tetiana Korzun; Ov D Slayden; Oleh Taratula
Journal:  Small       Date:  2021-01-25       Impact factor: 13.281

8.  Techniques for fluorescence detection of protoporphyrin IX in skin cancers associated with photodynamic therapy.

Authors:  Kishore R Rollakanti; Stephen C Kanick; Scott C Davis; Brian W Pogue; Edward V Maytin
Journal:  Photonics Lasers Med       Date:  2013-11-01

9.  Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by ABCG2 inhibitors in renal cell carcinoma cells.

Authors:  Richard Howley; Matthew Mansi; Janhavi Shinde; Juliana Restrepo; Bin Chen
Journal:  J Photochem Photobiol B       Date:  2020-09-05       Impact factor: 6.252

10.  Detection of cervical lesions by multivariate analysis of diffuse reflectance spectra: a clinical study.

Authors:  Vasumathi Gopala Prabitha; Sambasivan Suchetha; Jayaraj Lalitha Jayanthi; Kamalasanan Vijayakumary Baiju; Prabhakaran Rema; Koyippurath Anuraj; Anita Mathews; Paul Sebastian; Narayanan Subhash
Journal:  Lasers Med Sci       Date:  2015-10-31       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.